Bill Gillette
Bill Gillette is a freelance writer based in Richmond Heights, Ohio.
GEP test for melanoma proves accurate in validation study
results of a clinical validation study suggest that a new gene expression profile (GEP) test is effective for cutaneous melanoma. Find out how.
Overproduced protein tied to melanoma
A protein found on the surface of healthy skin cells could be linked to melanoma when overproduced, according to a new study.
Biologic therapies not linked to cancer
Recently developed biologic therapies developed for treating rheumatoid arthritis are not associated with an increased risk of cancer, according to investigators from the University of Texas MD Anderson Cancer Center.
Pioneer skin researcher dies
Richard Winkelmann, M.D., a physician and pioneering dermatology and pathology researcher at the Mayo Clinic, died of pancreatic cancer at his home in Rochester recently. He was 88.
Noninvasive laser tightens skin
Noninvasive CO2 laser resurfacing treatments have shown effectiveness in skin tightening, according to a study published recently.
MicroRNAs inhibit venous ulcer healing
Aberrantly expressed micro ribonucleic acids (miRNAs) may slow healing of chronic venous ulcers, a new study suggests.
Bacteria-laden mites may cause rosacea
Bacteria carried by mites on the skin may be the cause of rosacea, according to results of a new study.
Valeant to buy Medicis for $2.6B
Valeant Pharmaceuticals has agreed to buy Medicis Pharmaceutical in a deal valued at about $2.6 billion. The transaction is expected to close in the first half of 2013.
Educated patients more likely to ID melanoma
Patients who undergo an interactive education program, including skin self-examination (SSE) tutorials and telecommunications reminders, are more likely to identify melanoma, according to a recently published study.
Tanning industry vilifies health authorities
Tanning salon owners in the United States are going on the offensive against physicians and other healthcare professionals in an attempt to maintain an industry worth nearly $5 billion a year.

Poll